At EAN 2022, Dr Henrik Schytz, discussed how there is not a lot of stigma attached to medication overuse headache (MOH) from the healthcare professional (HCP) perspective. MOH may be challenging for HCPs as ‘treatment’ involves stopping pain-relieving medication, which they may view as wrong. Patients with MOH need to be followed up as once the causative medication is stopped, they may return to it and new ways might be needed to help them. In some countries, preventative medication is indicated at the time of withdrawal of acute medication, which, Dr Schytz proposed, may relieve the HCP of feeling they are not treating their patient.
MOH: medication overuse headache
HCP: health care professional
Disclaimer: The video represent the opinion of the speaker. Lundbeck does not recommend the use of drugs outside of its registered indications. Please always consult the Summary of Product Characteristics.
BE-NOTPR-0284; approval date 05/2023
